Evidence map›Paper›PMID 30158681›Full record

ArticleNature genetics2018

Genetic risks and clinical rewards.

Andrew J Schork, M Anthony Schork, Nicholas J Schork

Registry-linked trialAbstract readComment
In one paragraph

Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04331535 (Pragmatic Randomized Trial of Polygenic Risk Scoring for Common Diseases in Primary Care), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04331535 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Pragmatic Randomized Trial of Polygenic Risk Scoring for Common Diseases in Primary Care

TypeinterventionalSponsorBoston VA Research Institute, Inc.Ran2020 to 2025Enrolled1,076ConditionsCoronary Artery Disease, Atrial Fibrillation, Type 2 Diabetes, Colorectal CancerArmsPolygenic risk score (PRS)
3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Holy Grail: the journey towards disease modification in asthma.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Strategies for Testing Intervention Matching Schemes in Cancer.Clinical pharmacology and therapeutics · 2020
    Review
  13. Genetic Risk Scores.Current protocols in human genetics · 2019
    Review
  14. Review
  15. Article
  16. Artificial Intelligence and Personalized Medicine.Cancer treatment and research · 2019
    Article
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Andrew J SchorkInstitute for Biological Psychiatry, Mental Health Services Snct. Hans, Roskilde, Denmark.
M Anthony SchorkDepartment of Biostatistics (Emeritus), University of Michigan, Ann Arbor, MI, USA.
Nicholas J SchorkDepartment of Quantitative Medicine, The Translational Genomics Research Institute (TGen), Phoenix, AZ, USA. nschork@tgen.org.

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
Integrative Resource to Develop Translational Strategies to Promote LongevityU24AG051129 · NIA · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI CUMMINGS, STEVEN RON, EVANS, DANIEL SPENCER · 2015 to 2019
$5.3M
NCATS NIH HHS UL1 TR001442NIA NIH HHS U24 AG051129
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RewardHumansMutation

Identifiers

PMID30158681
PMCPMC6383764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.